Table 3.
Relationship of VL and Coinfection to LRTI | OR (95% CI) |
---|---|
Association of LRTI with higher VL | |
All HRV illness episodes | |
Univariate analysis | 1.50 (0.97–2.32) |
Multivariate analysis* | 1.57 (0.99–2.51) |
HRV-only illness episodes | |
Univariate analysis | 1.90 (1.17–3.09) |
Multivariate analysis* | 2.11 (1.24–3.58) |
Sensitivity analysis (effect of decreasing CT value by 5 units) | |
All HRV illness episodes | |
Univariate analysis | 1.14 (0.94–1.39) |
Multivariate analysis* | 1.15 (0.94–1.42) |
HRV-only illness episodes | |
Univariate analysis | 1.26 (1.01–1.57) |
Multivariate analysis* | 1.28 (1.01–1.62) |
Association of coinfection with higher VL | |
Univariate analysis | 0.51 (0.29–0.88) |
Multivariate analysis* | 0.38 (0.21–0.69) |
Association of coinfection with LRTI | |
Univariate analysis | 1.74 (0.99–3.05) |
Multivariate analysis* | 1.83 (1.01–3.32) |
*Adjusted for age (<12 months or ≥12 months), gender, race (white, black, Asian, Native Hawaiian/Pacific Islander, American Indian/Alaska native, more than race 1, or other race), underlying disease (yes or no), and premature birth.